Quantum Genesis AI Corp. (QGAI) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
15656 BERNARDO CENTER DRIVE, #801 SAN DIEGO, CA 92127 |
| State of Incorp. | NV |
| Fiscal Year End | July 31 |
| Industry (SIC) | 286 - Industrial Organic Chemicals (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 1/31/2026 MRQ | 7/31/2025 | 7/31/2018 | 7/31/2017 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 3 | |||||
| Cash and cash equivalent | 3 | |||||
| Receivables | 5 | |||||
| Other undisclosed current assets | 1 | |||||
| Total current assets: | 1 | 7 | ||||
| Noncurrent Assets | ||||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 11 | |||||
| Total noncurrent assets: | 11 | |||||
| TOTAL ASSETS: | 1 | 18 | ||||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities, including: | 175 | 9 | ||||
| Accounts payable | 1 | |||||
| Accrued liabilities | 8 | |||||
| Other undisclosed accounts payable and accrued liabilities | 175 | |||||
| Debt | 249 | |||||
| Due to related parties | ✕ | ✕ | 0 | |||
| Other undisclosed current liabilities | 17 | |||||
| Total current liabilities: | 441 | 9 | 0 | |||
| Noncurrent Liabilities | ||||||
| Total liabilities: | 441 | 9 | 0 | |||
| Equity | ||||||
| Equity, attributable to parent, including: | (441) | (9) | 18 | |||
| Common stock | 0 | 5 | 5 | |||
| Additional paid in capital | 5,195 | 41 | 40 | |||
| Accumulated deficit | (5,637) | (55) | (27) | |||
| Other undisclosed equity, attributable to parent | 0 | |||||
| Total equity: | (441) | (9) | 18 | |||
| TOTAL LIABILITIES AND EQUITY: | 1 | 18 | ||||
Income Statement (P&L) ($ in thousands)
| 1/31/2026 TTM | 7/31/2025 | 7/31/2018 | 7/31/2017 | ||
|---|---|---|---|---|---|
| Revenues | 94 | 128 | |||
| Revenue, net | ✕ | ✕ | ✕ | 128 | |
| Cost of revenue (Cost of Product and Service Sold) | (89) | (106) | |||
| Gross profit: | 4 | 22 | |||
| Operating expenses | (181) | (17) | (61) | ||
| Operating loss: | (181) | (13) | (39) | ||
| Nonoperating expense (Other Nonoperating expense) | (19) | (15) | |||
| Interest and debt expense | 3 | ||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | |||||
| Loss from continuing operations before equity method investments, income taxes: | (197) | (28) | (39) | ||
| Other undisclosed loss from continuing operations before income taxes | (3) | ||||
| Loss from continuing operations before income taxes: | (199) | (28) | (39) | ||
| Income tax benefit | 5 | ||||
| Loss from continuing operations: | (199) | (28) | (34) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (28) | (34) | |
| Other undisclosed net income | 1 | ||||
| Net loss available to common stockholders, diluted: | (199) | (28) | (33) | ||
Comprehensive Income ($ in thousands)
| 1/31/2026 TTM | 7/31/2025 | 7/31/2018 | 7/31/2017 | ||
|---|---|---|---|---|---|
| Net loss: | (199) | (28) | (33) | ||
| Comprehensive loss, net of tax, attributable to parent: | (199) | (28) | (33) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.